Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients with Chronic Kidney Disease
PHASE1CompletedINTERVENTIONAL
Enrollment
29
Participants
Timeline
Start Date
October 6, 2016
Primary Completion Date
July 6, 2017
Study Completion Date
July 6, 2017
Conditions
Chronic Kidney Disease
Interventions
DRUG
TS-143
Trial Locations (1)
Unknown
Taisho Pharmaceutical Co., Ltd selected site, Tokyo and Other Japanese City
All Listed Sponsors
lead
Taisho Pharmaceutical Co., Ltd.
INDUSTRY
NCT03581071 - Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients with Chronic Kidney Disease | Biotech Hunter | Biotech Hunter